WELLINGTON MANAGEMENT GROUP LLP - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 168 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.3%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$164,387,787
+60.9%
8,022,830
+56.0%
0.03%
+73.7%
Q2 2023$102,180,621
+45.2%
5,142,457
+25.2%
0.02%
+35.7%
Q1 2023$70,368,806
+2.5%
4,107,928
+17.1%
0.01%0.0%
Q4 2022$68,632,322
+23.6%
3,507,017
+0.8%
0.01%
+16.7%
Q3 2022$55,516,000
+18.4%
3,478,412
+2.1%
0.01%
+33.3%
Q2 2022$46,869,000
-14.9%
3,406,129
-1.9%
0.01%0.0%
Q1 2022$55,076,000
-27.7%
3,472,641
-0.5%
0.01%
-25.0%
Q4 2021$76,206,000
-23.8%
3,490,879
+4.3%
0.01%
-29.4%
Q3 2021$100,017,000
-46.5%
3,346,231
-20.7%
0.02%
-45.2%
Q2 2021$186,815,000
+15.1%
4,217,975
+15.3%
0.03%
+6.9%
Q1 2021$162,354,000
+10.4%
3,659,077
+36.5%
0.03%
+7.4%
Q4 2020$147,054,000
+282.5%
2,681,521
+59.5%
0.03%
+237.5%
Q3 2020$38,441,000
+8.7%
1,681,605
-0.4%
0.01%0.0%
Q2 2020$35,351,000
+50.9%
1,688,990
+0.6%
0.01%
+33.3%
Q1 2020$23,428,000
-41.7%
1,679,480
-4.9%
0.01%
-25.0%
Q4 2019$40,186,000
+95.9%
1,765,645
+0.3%
0.01%
+60.0%
Q3 2019$20,517,000
+284.4%
1,761,071
+394.9%
0.01%
+400.0%
Q2 2019$5,338,000
+11.5%
355,868
+30.4%
0.00%0.0%
Q1 2019$4,787,000272,8960.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
M28 Capital Management LP 715,880$11,354,00010.44%
RTW INVESTMENTS, LP 15,802,802$250,632,0005.19%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 63,000$17,884,0004.03%
TANG CAPITAL MANAGEMENT LLC 1,265,900$20,077,0004.02%
Prosight Management, LP 203,268$3,224,0002.08%
COWEN AND COMPANY, LLC 1,000,000$15,860,0001.53%
Boxer Capital, LLC 1,466,051$23,252,0001.20%
Cormorant Asset Management, LP 868,550$13,775,0001.06%
Amitell Capital Pte Ltd 97,331$1,544,0000.90%
SECTORAL ASSET MANAGEMENT INC 303,975$4,821,0000.86%
View complete list of ROCKET PHARMACEUTICALS INC shareholders